Paul SM

References (3)

Title : Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease - Bodick_1997_Arch.Neurol_54_465
Author(s) : Bodick NC , Offen WW , Levey AI , Cutler NR , Gauthier SG , Satlin A , Shannon HE , Tollefson GD , Rasmussen K , Bymaster FP , Hurley DJ , Potter WZ , Paul SM
Ref : Archives of Neurology , 54 :465 , 1997
Abstract :
PubMedSearch : Bodick_1997_Arch.Neurol_54_465
PubMedID: 9109749

Title : The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease - Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16
Author(s) : Bodick NC , Offen WW , Shannon HE , Satterwhite J , Lucas R , van Lier R , Paul SM
Ref : Alzheimer Disease & Associated Disorders , 11 Suppl 4 :S16 , 1997
Abstract :
PubMedSearch : Bodick_1997_Alzheimer.Dis.Assoc.Disord_11 Suppl 4_S16
PubMedID: 9339268

Title : Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin - Clarke_1985_J.Neurosci_5_1307
Author(s) : Clarke PB , Schwartz RD , Paul SM , Pert CB , Pert A
Ref : Journal of Neuroscience , 5 :1307 , 1985
Abstract :
PubMedSearch : Clarke_1985_J.Neurosci_5_1307
PubMedID: 3998824